Semaglutide and Alcohol: What the Labels Say and What Research Shows

Quick answer

As of September 2026, none of the prescribing information for the 3 FDA-approved semaglutide brands (Wegovy, Ozempic injection and tablets, and Rybelsus) says anything about semaglutide and alcohol: no alcohol warning, no alcohol interaction, and no line telling patients to avoid alcohol; the only mentions of alcohol in all three are the alcohol swabs in the injection instructions. That silence is not a green light. The same labels warn about pancreatitis, low blood sugar, dehydration that can injure the kidneys, and severe stomach reactions, and heavy drinking contributes to each of those on its own. Drinking on semaglutide is a question for the physician who prescribed it and knows your history; what follows is the label text, the research, and the questions to bring to that conversation.

Can you drink on semaglutide? What the labels say

The prescribing information does not decide this for you. A search of the full text of the current Wegovy label (DailyMed, version 19, effective June 18, 2026), the Ozempic injection label (version 20, effective June 1, 2026), and the Rybelsus and Ozempic tablets label (version 14, effective January 30, 2026) for the word "alcohol" returns only one kind of result about drinking: the instruction to clean the injection site with an alcohol swab. (The Wegovy label also contains the string inside "nonalcoholic," the former name of the liver condition MASH, which is not a statement about drinking.) There is no contraindication, no drug interaction entry, and no counseling statement about drinking. (Often typed "semiglutide"; the spelling is semaglutide.)

What the labels do say is that the prescriber should know about your pancreas, your kidneys, and any diabetes medicines you take, and alcohol touches all three. So the practical answer is this: the label leaves it open, and a physician who knows how much you drink, why you were prescribed the medicine, and what else you take is the person who can answer it.

Where do alcohol and semaglutide overlap? Four label warnings

Four label warnings matter here. The quotes are from the Wegovy prescribing information; the Ozempic and Rybelsus labels carry near-identical language.

Acute pancreatitis (section 5.2). "Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including WEGOVY." The NIDDK lists the causes of pancreatitis as "gallstones, heavy alcohol use, medicines, and genetic disorders of the pancreas" and NIAAA states, "Alcohol misuse over time can lead to pancreatitis". Heavy drinking and a GLP-1 medicine are two separate risk factors for the same organ.

Hypoglycemia (sections 5.4 and 7.1). "WEGOVY lowers blood glucose and can cause hypoglycemia. The risk of hypoglycemia is increased when WEGOVY is used concomitantly with insulin or insulin secretagogues (e.g., sulfonylureas)." NIDDK supplies the alcohol half: "Alcohol makes it harder for your body to keep your blood glucose level steady, especially if you haven't eaten in a while. Alcohol can also keep you from feeling the first symptoms of low blood glucose".

Acute kidney injury due to volume depletion (section 5.5). "The majority of the reported events occurred in patients who experienced gastrointestinal adverse reactions leading to dehydration such as nausea, vomiting, or diarrhea." A night of drinking that ends in vomiting adds to exactly the fluid loss the label describes.

Severe gastrointestinal adverse reactions (section 5.6). "Use of WEGOVY has been associated with gastrointestinal adverse reactions, sometimes severe." The Medication Guide adds: "It is important for you to drink fluids to help reduce your chance of dehydration."

Why one drink can feel different on semaglutide

Label section 12.2 says it in four words: "Semaglutide delays gastric emptying." Section 7.2 notes that the delay "has the potential to impact the absorption" of oral medicines, and adds that in clinical pharmacology trials semaglutide "did not affect the absorption of orally administered medications." Alcohol is swallowed and passes through the same stomach, but no label study measured alcohol, so the pathway is documented and its effect on a drink is not.

How gastric emptying shapes alcohol absorption has been studied for decades. A 1989 study in the American Journal of Physiology found a close correlation between alcohol absorption and liquid emptying, with absorption fastest when the alcoholic drink was taken alone and slower when taken with or after solid food. A 1998 study in Gut reported that first pass metabolism of ethanol "is strikingly influenced by the speed of gastric emptying" and that delayed emptying "increases the time of exposure of ethanol to gastric ADH", the enzyme that begins breaking alcohol down in the stomach. Neither study involved semaglutide; they describe the pathway the label says semaglutide slows.

Three things change when you drink on semaglutide, and they can compound:

1. The stomach empties slower, so alcohol reaches the bloodstream on a different schedule than you are used to. The label documents the delay, not how a drink feels.
2. Meals are smaller. The medicine reduces appetite, and the absorption studies above show that alcohol taken without solid food is absorbed faster.
3. Tolerance feels lower. Many people report that one drink now feels like two. This is commonly reported and has not been quantified in controlled trials; treat it as an observation, not a finding.

Semaglutide and alcohol side effects: documented versus reported

Documented in the labels for the medicine itself, with or without alcohol: nausea, vomiting, diarrhea, and the dehydration and kidney strain that can follow; abdominal pain that may signal pancreatitis; low blood sugar in people who also take insulin or a sulfonylurea. Alcohol contributes to each of these in its own right, so the overlap is real even though no label quantifies it.

Reported by patients but not studied: feeling intoxicated faster, worse hangovers, poorer sleep after even one drink, and less desire to drink at all. NIAAA notes in general terms that "Certain medications can influence the absorption and metabolism of alcohol. The interaction can result in higher blood alcohol concentrations (BACs) and other adverse effects." Semaglutide does not appear in NIAAA's Harmful Interactions table, and silence in a reference table is not clearance.

A bad reaction is information. If a drink on semaglutide brought on severe nausea, vomiting, dizziness, or stomach pain that did not settle, tell your prescriber; the Medication Guide asks for that report right away.

Does semaglutide change how much people drink? What the trials found

Three randomized, placebo-controlled trials have now been published. All three are described in words; their effect sizes come from small studies and do not translate into what any one person should expect.

• JAMA Psychiatry, 2025 (PubMed 39937469). A nine-week phase 2 trial in non-treatment-seeking adults with alcohol use disorder. Weekly semaglutide reduced the amount of alcohol consumed in a laboratory self-administration task, reduced drinks per drinking day and weekly craving, and did not change the number of drinking days. The authors call the findings "initial prospective evidence" that justifies "larger clinical trials".
• The Lancet, 2026 (PubMed 42070571). A 26-week trial in Denmark in treatment-seeking adults with moderate to severe alcohol use disorder and obesity, on top of cognitive behavioral therapy. Heavy drinking days fell more with semaglutide than with placebo. The safety sentence: "Adverse events were transient, generally mild to moderate gastrointestinal effects, and occurred more frequently in the semaglutide group."
• American Journal of Psychiatry, 2026 (PubMed 42522065). An eight-week phase 2 trial of daily oral semaglutide in treatment-seeking adults. It did not significantly reduce laboratory cue-elicited craving or drinks per day, but it did reduce heavy drinking days, drinks per drinking day, everyday craving, and alcohol-related consequences. The American Psychiatric Association's July 29, 2026 release states the limit plainly: "GLP-1 receptor agonists, including semaglutide, are currently approved by the U.S. Food and Drug Administration for weight loss and for management of type 2 diabetes."

The trials build on preclinical work. NIAAA and NIDA scientists reported in 2023 that semaglutide "reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse", and the senior authors explained: "Parts of the brain that drive eating behaviors overlap extensively with the drive to use alcohol or other substances".

What this research is not: it is not an approved use. No GLP-1 medicine carries an alcohol use disorder indication, and reducing drinking is not an approved reason to prescribe semaglutide. If drinking is something you want help with, that is its own conversation with a physician, and medicines with an approved indication exist; oral naltrexone, for example, is "indicated in the treatment of alcohol dependence" (more on naltrexone here).

Is semaglutide hard on the liver?

The Wegovy label's Warnings and Precautions section has no liver warning. Its indications now include "the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis," and its pharmacodynamics section states, "Semaglutide decreases liver fat content" as measured by MRI. That indication says nothing about alcohol-related liver disease.

Alcohol is the separate variable. NIAAA: "Heavy drinking takes a toll on the liver, and can lead to a variety of problems and liver inflammations including" alcohol-associated steatosis, steatohepatitis, hepatitis, fibrosis, cirrhosis, and liver cancer. Liver disease, or drinking at the heavy-drinking level defined below, belongs in the first conversation with your prescriber, not the last.

What counts as a drink: NIAAA definitions

Physicians ask about drinks per week, and the answer only means something if a "drink" is defined. NIAAA: "In the United States, one standard drink contains about 14 grams, or about 0.6 fluid ounces, of pure alcohol." That is a 12-ounce can of regular beer at 5 percent alcohol by volume, a 5-ounce glass of wine at 12 percent, or a 1.5-ounce shot of distilled spirits at 40 percent.

NIAAA defines binge drinking as a pattern that brings blood alcohol concentration to 0.08 grams per deciliter or higher, which for a typical adult means "five or more drinks (male), or four or more drinks (female), in about two hours". It defines heavy drinking as, "For men, consuming five or more drinks on any day or 15 or more per week" and, "For women, consuming four or more on any day or eight or more drinks per week". NIAAA also states that "harms may be associated with any amount of drinking". No semaglutide label sets a drink limit; these definitions are the vocabulary for the conversation with your prescriber.

What your prescriber will ask about alcohol

The Wegovy Medication Guide tells patients to disclose, before starting, whether they "have or have had problems with your pancreas or kidneys", whether they "are scheduled to have surgery or other procedures that use anesthesia", and whether they "are taking other medicines to treat diabetes, including sulfonylureas or insulin". A physician weighing alcohol on semaglutide typically also asks:

• How many standard drinks in a typical week, and on the heaviest day?
• Any history of pancreatitis, gallbladder disease, liver disease, or alcohol use disorder?
• Do you take insulin, a sulfonylurea, or any other medicine that lowers blood sugar?
• Have you had nausea, vomiting, or diarrhea on the medicine, and did drinking make it worse?
• Are you in your first weeks on the medicine or just after a dose change, when the label asks for closer monitoring for dehydration?

Answer honestly. The point is to find the overlap between the label's warnings and your history and to decide together whether, how much, and when drinking is reasonable for you.

What not to mix with semaglutide

The labels name two interaction categories in section 7. First, "insulin or insulin secretagogues (e.g., sulfonylureas)", because of hypoglycemia. Second, oral medicines whose absorption depends on the stomach emptying at its usual pace, because semaglutide "causes a delay of gastric emptying".

Alcohol appears in neither category. NIAAA's Harmful Interactions table lists alcohol interactions for diabetes medicines such as sulfonylureas and metformin and has no entry for any GLP-1 receptor agonist. Read that as not listed, not as cleared.

When to call your doctor

Call if you notice the label's warning signs, after drinking or not. Pancreatitis: "severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back." Low blood sugar: dizziness, sweating, shakiness, blurred vision, slurred speech, confusion, or a fast heartbeat. Dehydration: "nausea, vomiting, or diarrhea that does not go away". Several of these overlap with being drunk or hungover, which is one more reason a physician, not a guess, should sort them out.

For everyday reactions, see managing GLP-1 side effects, the semaglutide side effects guide, and what to eat on semaglutide. If you also have headaches or tiredness, alcohol and poor sleep belong in the same conversation. The mechanism is explained in the science behind GLP-1 and semaglutide.

A note on compounded semaglutide

Compounded medications are not FDA-approved as final products. A compounded semaglutide product has no FDA label of its own; the Wegovy, Ozempic and Rybelsus labels quoted here describe the approved products, not any compounded product. The FDA's position: "Compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug."

This article is for informational purposes only and does not constitute medical advice. Medication is prescribed only if a licensed physician determines it is appropriate. Always talk with your own physician before combining alcohol with any prescription medicine.